Codexis to Present Update on ECO Synthesis™ Platform at TIDES Europe
26 oct. 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced a presentation highlighting the role of an enzymatic...
Codexis to Report Third Quarter 2023 Financial Results on November 2
19 oct. 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the third...
Codexis CEO Stephen Dilly Wins Prestigious 2023 Bloom Burton Award
29 sept. 2023 07h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced President and Chief Executive Officer Stephen Dilly,...
Codexis CEO Stephen Dilly Named as Finalist of 2023 Bloom Burton Award
18 sept. 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced Stephen Dilly, MBBS, PhD, President and Chief Executive...
Codexis to Participate in Cantor Global Healthcare Conference
12 sept. 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company will attend the Cantor Global Healthcare...
Codexis Announces Agreement for Assignment and Assumption of San Carlos Facility Lease
07 sept. 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the Company has executed an Assignment and Assumption of...
Codexis Reports Second Quarter 2023 Financial Results
03 août 2023 16h05 HE
|
Codexis, Inc.
Company Recently Announced Enhanced Strategic Focus and Portfolio Prioritization Anticipate Demonstrating Gram-Scale Synthesis of ECO Synthesis™ Technology for RNAi Therapeutics...
Codexis Documentary Showcases its Specialized Capabilities Engineering High Performance Enzymes to Enable Delivery of Novel Therapeutics
31 juil. 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., July 31, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the launch of a new mini documentary as part of an ongoing...
Codexis Announces Enhanced Strategic Focus and Extends Projected Cash Runway to Mid-2026
20 juil. 2023 16h05 HE
|
Codexis, Inc.
Organization Streamlined to Focus on Continued Advancement and Commercialization of ECO Synthesis™ Platform for RNAi Therapeutics Production Codexis Expects its Pharmaceutical Manufacturing Business...
Codexis Announces New Employment Inducement Grants
09 juin 2023 16h05 HE
|
Codexis, Inc.
REDWOOD CITY, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to four new employees as...